Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Metab Brain Dis ; 7(4): 183-96, 1992 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-1294868

RESUMO

Cellular volume regulation following swelling in hypo-osmotic phosphate-buffered saline (PBS) and ATP and phosphocreatine concentrations of cells incubated in iso-osmotic or hypo-osmotic PBS were measured in primary cultured rat cerebral astrocytes exposed for 30 min to NH4Cl, salicylate, hexanoate, octanoate, and/or dodecanoate. These compounds have been implicated in the pathogenesis of cerebral edema in Reye's Syndrome. NH4Cl (0.10 - 10 mM) had no effect on astrocyte volume regulation or ATP concentration. Salicylate significantly reduced ATP concentrations at 3.0 mM and 10 mM but had no effect on volume regulation. Hexanoate (10 mM and 30 mM) decreased astrocyte ATP content by over 80% while octanoate (10 mM) reduced ATP content by more than 50%. Concentrations of these fatty acids at or below 3.0 mM had no effect on ATP content. Volume regulation was inhibited by 3.0 mM hexanoate and 3.0 mM octanoate but not lower concentrations. Dodecanoate (0.1-3.0 mM) decreased cellular ATP content by 33-51% in iso-osmotic PBS solutions. Phosphocreatine content was reduced by exposure to salicylate or octanoate at concentrations which had no effect on ATP content. These results indicate that astrocyte energy metabolism and volume regulation may be compromised by agents associated with cerebral edema in Reye's Syndrome. Analysis of the dose-dependence of these effects suggests that inhibition of astrocyte energy metabolism is not sufficient to affect volume regulation.


Assuntos
Trifosfato de Adenosina/metabolismo , Amônia/farmacologia , Astrócitos/metabolismo , Ácidos Graxos/farmacologia , Fosfocreatina/metabolismo , Salicilatos/farmacologia , Animais , Astrócitos/citologia , Células Cultivadas , Combinação de Medicamentos , Concentração Osmolar , Ácido Salicílico
2.
J Appl Physiol (1985) ; 64(5): 1837-43, 1988 May.
Artigo em Inglês | MEDLINE | ID: mdl-3391887

RESUMO

We designed experiments to evaluate changes in ventral medullary (VM) extracellular fluid (ECF) PCO2 and pH during hypoxemia-induced ventilatory depression (VD). Our aim was to investigate effects of aminophylline on VD and VM ECF acid-base variables. We used aminophylline because it inhibits adenosine, which is released within the brain during hypoxemia and could mediate VD. Experiments were performed in seven cats with acute bilateral denervation of carotid sinus nerves and vagi. Cats were anesthetized with chloralose-urethan and breathed spontaneously at a regulated and elevated arterial PCO2 (PaCO2). Measurements were made during normoxemia, hypoxemia, and recovery before (phase I) and after (phase II) aminophylline. By use of strict criteria for definition of VD, during phase II two kinds of responses were observed. Aminophylline prevented VD in five cats. In these cats in phase I, with mean arterial PO2 (PaO2) = 105 and PaCO2 = 42.2 Torr, VM ECF PCO2, [H+], and [HCO3-] were 59.5 +/- 8.6 Torr (mean +/- SD), 60.2 +/- 9.4 neq/l, and 23.1 +/- 3.7 meq/l, respectively. When mean PaO2 dropped to 49 Torr, ventilation decreased 21%, with only small changes in VM ECF acid-base variables. Studies were repeated 30 min after aminophylline (17 mg/kg iv). In phase II, during normoxemia (PaO2 = 110 Torr) VM ECF Pco2, [H+], and [HCO3-] were 55.4 +/- 8.1 Torr, 62.0 +/- 8.0 neq/l and 20.7 +/- 2.5 meq/l, respectively. During hypoxemia (PaO2 = 48 +/- 4 Torr) mean ventilation, VM ECF PCO2, [H+], and [HCO3-] did not change significantly.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Aminofilina/farmacologia , Hipóxia/fisiopatologia , Respiração/efeitos dos fármacos , Animais , Gasometria , Gatos , Hipóxia/sangue
3.
Respir Physiol ; 61(3): 301-16, 1985 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-4059689

RESUMO

The aim of the present experiments in artificially ventilated, anesthetized cats was to investigate in which circumstances the timing of the arterial blood gas oscillations within the respiratory cycle can be of importance in determining phrenic motoneurone output. The phase relationship phi was defined as the relative position of the peak of the phrenic bursts within the current continuously measured PaO2 oscillations. It was judged breath by breath whether there was a relationship between phi and neural tidal volume, and neural inspiratory and expiratory duration. Within cats, PETCO2 was kept constant at about 1.5-2% above apneic threshold. It was found that phi indeed partly determined these ventilatory parameters provided the oscillations were large enough. This was evident in normoxia; in moderate hypoxia the influence of phi was demonstrable more easily, i.e. at smaller oscillation amplitudes. In both conditions the effect of phi on neural tidal volume was most pronounced. Neural tidal volume was maximal when peak inspiration coincided with the expiratory trough of the PaO2 oscillations. A 1:1 phase lock between phrenic activity and the ventilatory only occurred when the pump frequency was close to the cats own breathing frequency. Bilateral carotid sinus nerve section abolished the effects of phi.


Assuntos
Neurônios Motores/fisiologia , Oxigênio/sangue , Nervo Frênico/fisiologia , Respiração , Animais , Artérias , Gatos , Feminino , Hipóxia/fisiopatologia , Masculino , Periodicidade , Troca Gasosa Pulmonar , Respiração Artificial , Volume de Ventilação Pulmonar , Vagotomia
4.
Can Med Assoc J ; 128(11): 1291-5, 1983 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-6342739

RESUMO

Initial adjuvant immunotherapy trials have demonstrated a greater disease-free interval in patients treated with bacille Calmette-Guérin (BCG) compared with historical controls. In this study 149 patients at high risk of recurrence after surgical treatment of local or regional malignant melanoma were given BCG for 2 years and were followed up for a median of 28 months from the start of immunotherapy. The 36 patients in the comparison group had a higher rate of recurrence than the patients treated with BCG, and the rate in the treatment group was close to that reported from a similar study at the University of California at Los Angeles. The relatively long disease-free interval for the high-risk comparison patients in this study suggests that the control groups at other centres may have included patients with unrecognized additional risk. The rates of survival in the Canadian treatment group were also comparable to those reported by other centres. However, reports of a favourable BCG-mediated pattern of recurrence could not be confirmed. Therefore, the routine use of adjuvant BCG immunotherapy is not recommended.


Assuntos
Vacina BCG/uso terapêutico , Melanoma/terapia , Neoplasias Cutâneas/terapia , Adulto , Idoso , Ensaios Clínicos como Assunto , Feminino , Humanos , Metástase Linfática , Masculino , Melanoma/mortalidade , Melanoma/cirurgia , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Cuidados Pós-Operatórios , Recidiva , Neoplasias Cutâneas/mortalidade , Neoplasias Cutâneas/cirurgia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA